NOT-DA-17-020: Notice of Change in the Expiration Date for PA-14-083 "Neuroimmune Signaling and Function in Substance Use Disorders (R21)"

Notice of Change in the Expiration Date for PA-14-083 "Neuroimmune Signaling and Function in Substance Use Disorders (R21)"

Notice Number: NOT-DA-17-020

Key Dates
Release Date: April 12, 2017

Related Announcements
PA-14-083

Issued by
National Institute on Drug Abuse (NIDA)

Purpose

The purpose of this Notice is to inform applicants of the change in the expiration date for FOA PA-14-083; Neuroimmune Signaling and Function in Substance Use Disorders (R21).

FOA currently read:

Part 2. Key Dates

Expiration date May 8, 2017

FOA modified to read:

Part 2. Key Dates

Expiration date January 8, 2018

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Roger G Sorensen, Ph.D., MPA
National Institute on Drug Abuse (NIDA)
Telephone: 301-443-3205
Email: [email protected]